Sort
50,496 grants matching “lung cancer”
National Lung Study Trial
$1,097,882Lance L Yokochi · Pacific Health Research Institute · N01 · FY2009 · CA
INHIBITION OF CARCINOGENESIS BY TEA AND TEA CONSTITUENTS
$1,097,872Rutgers The St Univ Of Nj New Brunswick · P01 · FY2001 · CA
Novel Targets for Vaccine Therapy
$1,097,667Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Signal Transduction Events and the Regulation of Cell Growth
$1,097,545Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2020 · CA
Signal Processing And Instrumentation Section
$1,097,447Thomas J Pohida · Center For Information Technology · ZIA · FY2015 · CT
Transgenic Models for Prostate and Breast Cancer
$1,095,844Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Heritable Neurodegenerative and Autoimmune Disorders
$1,095,625Anil B Mukherjee · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
DCTD Human Toxicology and Pharmacology
$1,095,585David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA
Molecular Cytogenetics of Solid Tumors
$1,095,529Nicolae Popescu · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Anastrozole in Pulmonary Arterial Hypertension (AIPH2) - CCC (Lead)
$1,094,913Steven M Kawut · University Of Pennsylvania · R01 · FY2020 · HL
Cell and Cancer Biology Branch Confocal Microscopy Core
$1,094,766Yvona Ward · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,094,655Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
A Randomized Phase II Trial of Low Dose Aspirin versus Placebo in High-Risk Indiv
$1,094,406Terisa Davis · University Of Tx Md Anderson Can Ctr · N03 · FY2013 · CA
CEACAM5-targeted activation of potent chemotherapeutics via bioorthogonal click chemistry
$1,094,189Jose M Mejia Oneto · Shasqi, Inc. · R44 · FY2025 · CA
NRG Oncology Network Group Operations Center
$1,094,150Norman Wolmark · Nrg Oncology Foundation, Inc. · U10 · FY2023 · CA
ASIAN AMERICAN NETWORK FOR CANCER AWAREN. RESEARCH &TRG
$1,093,389University Of California Davis · U01 · FY2005 · CA
New Mexico NIEHS Center
$1,093,317University Of New Mexico · P30 · FY2005 · ES
A Phase II Trial of ACAPHA in Former Smokers with IEN.
$1,092,902British Columbia Cancer Agency · U01 · FY2003 · CA
Epigenomics of T cells and innate immune cells in human asthma
$1,092,337Anjana Rao · La Jolla Institute For Immunology · R01 · FY2014 · HL
Targeted Discovery of Marine-derived Anticancer Leads
$1,092,108Phil Crews · University Of California Santa Cruz · U19 · FY2008 · CA
Outcomes in Rheumatic Diseases
$1,092,005Michael Ward · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2010 · AR
CANTRANce: A tool to translate intermediate endpoints to mortality in CE studies
$1,091,952Ruth D Etzioni · Fred Hutchinson Cancer Research Center · RC4 · FY2010 · CA
Stanford Project 2
$1,091,369Calvin J Kuo · University Of California, San Francisco · U54 · FY2017 · CA
Practical high resolution microscopy of un-cut, un-embedded lung biopsies
$1,091,279Michael John Levene · Applikate Technologies, Inc. · R44 · FY2017 · CA
Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section
$1,090,698Noemi Kedei · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA